Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)
Clinical trial NCT02368691 · TERMINATED
Trial details
- NCT number
- NCT02368691
- Sponsor
- GTx
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-09-22
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.